REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 68 filers reported holding REDHILL BIOPHARMA LTD in Q4 2020. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $702 | -82.4% | 5,000 | -28.6% | 0.00% | – |
| Q3 2022 | $4,000 | -42.9% | 7,000 | -6.7% | 0.00% | – |
| Q2 2022 | $7,000 | -63.2% | 7,500 | 0.0% | 0.00% | – |
| Q1 2022 | $19,000 | 0.0% | 7,500 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | -44.1% | 7,500 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $34,000 | -34.6% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $52,000 | -100.0% | 7,500 | -50.0% | 0.00% | 0.0% |
| Q1 2021 | $109,800,000 | +274400.0% | 15,000 | +200.0% | 0.00% | 0.0% |
| Q4 2020 | $40,000 | +1233.3% | 5,000 | +900.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |